Biotech solutions company
Imcheck Therapeutics has raised €219M across 4 funding rounds from 11 investors, most recently a round in Jun 2022. Based in Marseille, France; active in Healthtech. Acquired by Ipsen in 2025. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-14 | Other | €96M | Andera Partners,Earlybird,Invus fund,Leukemia and Lymphoma Society | View deal → |
| 2020-09-15 | Other |
| €54M |
| Bpifrance,Pfizer Venture Investments |
| View deal → |
| 2019-10-01 | Series B | €49M | Bpifrance,Pfizer Venture Investments | View deal → |
| 2017-05-09 | Other | €20M | Boehringer Ingelheim Venture Fund,GIMV,IDInvest Partners,Kurma Partners,LSP | View deal → |
